Rinne, Sanni
Michels, Birgitta
Butt, Julia
Syrjänen, Kari
Grenman, Seija
Waterboer, Tim
Syrjänen, Stina
Louvanto, Karolina
Funding for this research was provided by:
Päivikki ja Sakari Sohlbergin Säätiö
Research Council of Finland
Sigrid Juséliuksen Säätiö
Suomen Lääketieteen Säätiö
Article History
Received: 2 March 2026
Accepted: 19 May 2026
First Online: 29 May 2026
Declarations
:
: TW serves on advisory boards for Merck (MSD) Sharp & Dohme. The other authors declare no conflicts of interest.
: The original study protocol and its subsequent amendments were approved by the Research Ethics Committee of Turku University Hospital, Finland (#3/1998, #2/2006, 45/180/2010 and 329/2018) in accordance with the Declaration of Helsinki. Informed written consent was obtained from all participants of the study.